Samsung Australia Launches Game-Changing Health and Medical Equipment Division

By Admin
Samsung has launched a health and medical equipment group in its Australian business to drive quality care to patients with innovative diagnostic soluti...

Samsung has launched a health and medical equipment group in its Australian business to drive quality care to patients with innovative diagnostic solutions.

With Jamie Brand as the head of the new business division, the technology giant is enabling healthcare providers to provide more patient-centric care while also delivering high quality treatment with its top-of-the-line medical equipment.

Coinciding with its first global sale in Australia of the RS80A premium ultrasound systems designed for radiology diagnosis, Samsung is “bringing imaging and diagnostic technology innovations into the Australian healthcare sector,” according to Craig Gledhill, Samsung’s vice president of its Enterprise Business Team.

Combining imaging technology with high usability, the RS80A has advanced the way ultrasounds are captured. With the help of a mobile application, video clips can be downloaded to a mobile phone and updated scans can be provided every time a check-up takes place – far more beneficial than the common black-and-white photo.

Gledhill added that the company has identified healthcare as a key vertical globally that needs to be paid attention to, invested in and expanded, and the Australian region is key to that goal.

Involved in technology and health since 1985, Samsung has now seen the time as beneficial to establish a dedicated medical division in Australia.

“Through collaborative technologies that enable facilities to streamline administrative functions while providing seamless, secure access to confidential patient records, physicians can devote more time to patient needs,” said Wayne Spittle, Samsung Medisons’ (a subsidiary of Samsung electronics) executive vice president.

Samsung is “dedicated to simplifying and accelerating patient care through the seamless integration of new technologies in a changing medical environment,” he added. 

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare